Nymox Pharmaceutical Corp (NASDAQ:NYMX)

1.28
Delayed Data
As of Jul 06
 -0.05 / -3.76%
Today’s Change
0.33
Today|||52-Week Range
5.75
+220.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues3.1M3.1M3.4M2.9M
 
 
 
 
 
Cost of Goods Sold275.2K253.9K486.2K173.7K
 
 
 
 
 
Depreciation And Amortization14.7K10.4K9.1K6.6K
 
 
 
 
 
 
Operating ExpensesGross Income2.8M2.8M2.9M2.8M
 
 
 
 
 
General Expenses12.4M10.7M8.3M7.8M
 
 
 
 
 
Research And Development9.0M8.6M6.3M4.8M
 
 
 
 
 
Total Operating Expenses12.7M11.0M8.8M7.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.6M-7.9M-5.4M-5.0M
 
 
 
 
 
Extraordinary Credit0.000.000.00189.6K
 
 
Interest Expense On Debt0.000.00--86.8K
 
 
Other Expenses-39.9K-39.1K-27.0K-24.6K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.7M-7.9M-5.5M-4.9M
 
 
 
 
 
Income Taxes0.00-289.8K-555.0K-316.8K
 
 
 
 
Net Income-9.7M-7.6M-4.9M-4.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS32.7M33.2M34.1M35.3M
 
 
 
 
 
Shares To Calculate EPS Diluted32.7M33.2M34.1M35.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.30-$0.23-$0.14-$0.13
 
 
 
 
 
EPS Diluted-$0.30-$0.23-$0.14-$0.13
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account